gabapentin immediate-release (capsules, tablets, oral solution) — CareFirst (Caremark)
Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients age ≥ 3 years with epilepsy
Initial criteria
- Authorization may be granted when the patient is NOT taking more than 3600 mg per day of gabapentin.
Approval duration
12 months